Market cap
$95 Mln
Revenue (TTM)
$26 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 0.37 | 14.43 | 6.69 | 185.20 | 103.26 |
| EBIT | -51.50 | -16.88 | 2.02 | 12.69 | -194.64 |
| Net Profit | -45.65 | -12.32 | 0.83 | 18.36 | -189.12 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -304.91 | -2,375.21 | -249.47 | -269.09 | -396.18 |
| Net Margin
| -- | -2,596.43 | -- | -- | -- |
| Return on equity
| -56.46 | -75.17 | -80.79 | -49.90 | -38.68 |
| Return on Capital
| -55.82 | -70.18 | -79.73 | -49.35 | -38.38 |
| Return on Assets
| -45.90 | -54.82 | -62.83 | -41.54 | -33.32 |
| Debt to Equity (x)
| -- | -- | 0.02 | 0.01 | 0.01 |
Profitability
ROCE
-79.73
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
-79.73
|
-49.35
|
-38.38
|
-163.30
|
-20.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-80.79
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
-80.79
|
-49.90
|
-38.68
|
-177.60
|
-28.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-62.83
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
-62.83
|
-41.54
|
-33.32
|
-124.58
|
-11.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-249.47
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
-249.47
|
-269.09
|
-396.18
|
-10,942.30
|
-19.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-245.13
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
-245.13
|
-270.04
|
-374.67
|
-5,170.97
|
-21.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.07
--
Year on year growth in net sales
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
0.07
|
0.60
|
14.22
|
-0.93
|
17.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
1.09
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
1.09
|
-8.71
|
44.91
|
-4,012.10
|
89.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
3.15
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
3.15
|
-15.36
|
48.22
|
-3,065.32
|
85.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.02
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
0.02
|
0.01
|
0.01
|
0.00
|
-0.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
0.01
|
0.00
|
0.00
|
0.00
|
-0.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.59
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
3.59
|
4.72
|
9.56
|
9.90
|
0.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
3.28
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
3.28
|
4.48
|
9.46
|
9.90
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-420.91
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
-420.91
|
-283.70
|
-262.10
|
-164.55
|
-3.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
22.72
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
22.72
|
22.53
|
12.24
|
--
|
101.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.26
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
0.26
|
0.15
|
0.09
|
0.01
|
0.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
80.06
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
80.06
|
55.12
|
22.35
|
2,583.96
|
188.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
708.88
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
708.88
|
538.84
|
254.58
|
--
|
-591.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
486.58
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
486.58
|
612.24
|
1,362.23
|
5,843.34
|
2,938.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
302.37
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
302.37
|
-18.29
|
-1,085.30
|
-3,259.38
|
-3,341.33
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
EV/EBITDA
0.72
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
0.72
|
1.65
|
2.84
|
1.36
|
-2.33
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|